Houston health startup launches tool to revolutionize kidney care, reduce costs
Chronic Kidney Disease is expensive and common. In fact, 37 million Americans live with the condition. The winner of this...
Chronic Kidney Disease is expensive and common. In fact, 37 million Americans live with the condition. The winner of this...
Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of...
Roche and the U.S. Biomedical Advanced Research and Development Authority (BARDA) Burn and Blast Medical Countermeasures Program, are joining forces...
Wilmington, Delaware, United States – Transparency Market Research Inc, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Global cystatin C assay market...
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients...
A leading federal scientist claimed he wasn't allowed to keep investigating a mystery neurological illness that made dozens of people...